Download PDF
Thromb Haemost 1995; 74(01): 460-463
DOI: 10.1055/s-0038-1642722
Symposium
Platelet Vessel Wall and Fibrinogen Interactions
Schattauer GmbH Stuttgart

The Role of von Willebrand Factor and Fibrinogen in the Initiation of Platelet Adhesion to Thrombogenic Surfaces

Zaverio M Ruggeri
Room Research Laboratory for Arteriosclerosis and Thrombosis, Division of Experimental Thrombosis and Hemostasis, Departments of Molecular and Experimental Medicine and Vascular Biology The Scripps Research Institute, La Jolla, CA, USA
› Author Affiliations
Further Information

Publication History

Publication Date:
09 July 2018 (online)

Also available at
  PDF Download  Permissions and Reprints
 
  • 1 Weiss HJ. Platelet physiology and abnormalities of platelet function. N. Engl. J Med 1975; 293 (531) 580-588
    CrossrefPubMedGoogle Scholar
  • 2 Sixma JJ, Waster J. The hemostatic plug. Semin. Hematol 1977; 14: 265-299
    PubMedGoogle Scholar
  • 3 Falk E. Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden death: autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in total vascular occlusion.. Circulation 1985; 71: 699-708
    CrossrefPubMedGoogle Scholar
  • 4 Fuster V, Steele PM, Chesebro JH. Role of platelets and thrombosis in coronary atherosclerotic disease and sudden death. J Am Coll Cardiol 1985; 5: 175B-184B.
    CrossrefPubMedGoogle Scholar
  • 5 Davies MJ, Thomas AC, Knapman PA, Hangartner JR. Intramyocardial platelet aggregation in patients with unstable angina suffering sudden ischemic cardiac death. Circulation 1986; 73: 418-427
    CrossrefPubMedGoogle Scholar
  • 6 Fitzgerald DJ, Roy L, Catella F, Fitzgerald GA. Platelet activation in unstable coronary disease. N. Engl. J. Med 1986; 315: 983-989
    CrossrefPubMedGoogle Scholar
  • 7 Nieuwenhuis HK, Akkerman J WN, Houdijk WP M, Sixma JJ. Human blood platelets showing no response to collagen fail to express surface glycoprotein la. Nature 1985; 318: 470-472
    CrossrefPubMedGoogle Scholar
  • 8 Ruggeri ZM, De Marco L, Gatti L, Bade rR, Montgomery RR. Platelets have more than one binding site for von Willebrand factor. J. Clin. Invest. 1983; 72: 1-12
    CrossrefPubMedGoogle Scholar
  • 9 Plow EF, McEver RP, Coller BS, Woods Jr VL, Marguerie GA, Ginsberg MH. Related binding mechanisms for fibrinogen, fibronectin,von Willebrand factor, and thrombospondin on thrombin-stimulated human platelets. Blood 1985; 66: 724-727
    PubMedGoogle Scholar
  • 10 Coller BS, Peerschke El, Scudder LE, Sullivan CA. Studies with a murine monoclonal antibody that abolishes ristocetin-induced binding of von Willebrand factor to platelets: Additional evidence in support of GPIb as a platelet receptor for von Willebrand factor. Blood 1983; 61: 99-l10
    PubMedGoogle Scholar
  • 11 De Marco L, Mazzucato M, Masotti A, Fenton II JW, Ruggeri ZM. Function of glycoprotein Iba in platelet activation induced by a-thrombin. J. Biol. Chem. 1991; 266: 23776-23783
    PubMedGoogle Scholar
  • 12 Alevriadou BR, Moake JL, Turner NA, Ruggeri ZM, Folie BJ, Phillips MD, Schreiber AB, Hrinda ME, Mclntire LV. Real-time analysis of shear-dependent thrombus formation and its blockade by inhibitors of von Willebrand factor binding to platelets. Blood 1993; 81: 1263-1276
    PubMedGoogle Scholar
  • 13 Baumgartner HR. The role of blood flow in platelet adhesion, fibrin deposition and formation of mural thrombi. Microvasc.Res. 1973; 5: 167-179
    PubMedGoogle Scholar
  • 14 Sakariassen KS, Bolhuis PA, Sixma JJ. Human blood platelet adhesion to artery subendothelium is mediated by factor VUI/von Willebrand factor bound to the subendothelium. Nature 1979; 279: 636-638
    CrossrefPubMedGoogle Scholar
  • 15 Weiss HJ, Turitto VT, Baumgartner HR. Effect of shear rate on platelet interaction with subendothelium in citrated and native blood. I. Shear rate-dependent decrease of adhesion in von Willebrand’s disease and the Bemard-Soulier syndrome. J. Lab. Clin. Med 1978; 92: 750-764
    PubMedGoogle Scholar
  • 16 Turitto VT, Weiss HJ, Baumgartner HR. Platelet interaction with rabbit subendothelium in von Willebrand’s disease: altered thrombus formation distinct from defective platelet adhesion. J. Clin. Invest. 1984; 74: 1730-1741
    CrossrefPubMedGoogle Scholar
  • 17 Hantgan RR, Hindriks G, Taylor RG, Sixma JJ, de Groot PG, Glycoprotein lb. von Willebrand Factor, and glycoprotein Ilb.IIIa are all involved in platelet adhesion to fibrin in flowing whole blood. Blood 1990; 76: 345-353
    PubMedGoogle Scholar
  • 18 Titani K, Kumar S, Takio K, Ericsson LH, Wade RD, Ashida K, Walsh KA, Chopek MW, Sadler JE, Fujikawa K. Amino acid sequence of human von Willebrand factor. Biochemistry 1986; 25: 3171-3184
    CrossrefPubMedGoogle Scholar
  • 19 Sadler JE, Shelton-Inloes BB, Sorace JM, Harlan JM, Titani K, Davie EW. Cloning and characterization of two cDNAs coding for human von Willebrand factor. Proc. Natl. Acad. Sci. USA 1985; 82: 6394-6398
    CrossrefPubMedGoogle Scholar
  • 20 Ginsburg D, Handin RI, Bonthron DT, Donlon TA, Bruns G AP, Latt SA, Orkin SH. Human von Willebrand factor (vWF): Isolation of complementary DNA (cDNA) clones and chromosomal localization. Science 1985; 228: 1401-1406
    CrossrefPubMedGoogle Scholar
  • 21 Sadler JE, Shelton-Inloes BB, Sorace JM, Titani K. Cloning of cDNA and genomic DNA for human von Willebrand factor. Cold Spring Harbor Symposia on Quantitative Biology 1986; 51: 515-523
    CrossrefPubMedGoogle Scholar
  • 22 Mancuso DJ, Tuley EA, Westfield LA, Worrall NK, Shelton-Inloes BB, Sorace JM, Alevy YG, Sadler JE. Structure of the gene for human von Willebrand factor. J. Biol. Chem. 1989; 264: 19514-19527
    PubMedGoogle Scholar
  • 23 Mancuso DJ, Tuley EA, Westfield LA, Lester-Mancuso TL, Le Beau MM, Sorace JM, Sadler JE. Human von Willebrand factor gene and pseudogene: Structural analysis and differentiation by polymerase chain reaction. Biochemistry 1991; 30: 253-269
    CrossrefPubMedGoogle Scholar
  • 24 Ruggeri ZM, Ware J. von Willebrand factor. FASEB J. 1993; 7: 308-316
    CrossrefPubMedGoogle Scholar
  • 25 Fujimura Y, Titani K, Holland LZ, Russell SR, Roberts JR, Elder JH, Ruggeri ZM, Zimmerman TS. von Willebrand factor. A reduced and alkylated 52/48 kDa fragment beginning at amino acid residue 449 contains the domain interacting with platelet glycoprotein lb. J. Biol. Chem. 1986; 261: 381-385
    PubMedGoogle Scholar
  • 26 Shelton-Inloes BB, Titani K, Sadler JE. cDNA sequences for human von Willebrand factor reveal five types of repeated domains and five possible protein sequence polymorphisms. Biochemistry 1986; 25: 3164-3171
    CrossrefPubMedGoogle Scholar
  • 27 Andrews RK, Gorman JJ, Booth WJ, Corino GL, Castaldi PA, Bemdt MC. Cross-linking of a monomeric 39/34-kDa dispase fragment of von Willebrand factor (Leu-480/Val-481 -Gly-718) to the N-terminal region of the a-chain of membrane glycoprotein lb on intact platelets with Lis(sulfosuccinimidyl) suberate. Biochemistry 1989; 28: 8326-8336
    CrossrefPubMedGoogle Scholar
  • 28 Cruz MA, Handin RI, Wise RJ. The interaction of the von Willebrand factor-Al domain with platelet glycoprotein Ib/IX. J. Biol. Chem. 1993; 268: 21238-21245
    PubMedGoogle Scholar
  • 29 Gralnick HR, Williams S, McKeown L, Kramer W, Krutzsch H, Gorecki M, Pinet A, Garfinkel LI. A monomeric von Willebrand factor fragment, Leu-504-Ser-728, inhibits von Willebrand factor interaction with glycoprotein Ib-IX. Proc.Natl.Acad.Sci. 1992; 89: 7880-7884
    PubMedGoogle Scholar
  • 30 Sugimoto M, Dent J, McClintock RA, Ware J, Ruggeri ZM. Analysis of structure-function relationship in the platelet membrane glycoprotein Ib-binding domain of von Willebrand factor by expression of deletion mutants. J. Biol. Chem. 1993; 268: 12185-12192
    PubMedGoogle Scholar
  • 31 Howard MA, Firkin BG. Ristocetin A new tool in the investigation of platelet aggregation. Thromb. Haemost. 1971; 26: 362-369
    Article in Thieme ConnectPubMedGoogle Scholar
  • 32 Read MS, Shermer RW, Brinkhous KM. Venom coagglutinin: an activator of platelet aggregation dependent on von Willebrand factor. Proc. Natl. Acad. Sci. USA. 1978; 75: 4514-4518
    CrossrefPubMedGoogle Scholar
  • 33 Scott JP, Montgomery RR, Retzinger GS. Dimeric ristocetin flocculates proteins, binds to platelets, and mediates von Willebrand factor-dependent agglutination of platelets. J. Biol. Chem. 1991; 266: 8149-8155
    PubMedGoogle Scholar
  • 34 Read MS, Smith SV, Lamb MA, Brinkhous KM. Role of botrocetin in platelet agglutination: formation of an activated complex of botrocetin and von Willebrand factor. Blood 1989; 74: 1031-1035
    PubMedGoogle Scholar
  • 35 Andrews RK, Booth WJ, Gorman JJ, Castaldi PA, Bemdt MC. Purification of botrocetin from bothrops jararaca venom. Analysis ofbotrocetin-mediated interaction between von Willebrand factor and the human platelet membrane glycoprotein Ib-IX complex. Biochemistry 1989; 28: 8317-8326
    CrossrefPubMedGoogle Scholar
  • 36 Fujimura Y, Titani K, Usami Y, Suzuki M, Oyama R, Matsui T, Fukui H, Sugimoto M, Ruggeri ZM. Isolation and chemical characterization of two structurally and functionally distinct forms of botrocetin, the platelet coagglutinin isolated from the venom of bothrops jararaca. Biochemistry 1991; 30: 1957-1964
    CrossrefPubMedGoogle Scholar
  • 37 Ruggeri ZM, Pareti FI, Mannucci PM, Ciavarella N, Zimmerman TS. Heightened interaction between platelets and Factor VUI/von Willebrand factor in a new subtype of von Willebrand’s disease. N. Engl. J. Med. 1980; 302: 1047-1051
    CrossrefPubMedGoogle Scholar
  • 38 Ruggeri ZM, Zimmerman TS. Variant von Willebrand’s disease: characterization of two subtypes by analysis of multimeric composition of factor VUI/von Willebrand factor in plasma and platelets. J. din. Invest. 1980; 65: 1318-1325
    PubMedGoogle Scholar
  • 39 Ware J, Dent JA, Azuma H, Sugimoto M, Kyrle PA, Yoshioka A, Ruggeri ZM. Identification of a point mutation in Type IIB von Willebrand disease illustrating the regulation of von Willebrand factor affinity for the platelet GP Ib-IX receptor. Proc. Natl. Acad. Sci. USA 1991; 88: 2946-2950
    CrossrefPubMedGoogle Scholar
  • 40 Sugimoto M, Mohri H, McClintock RA, Ruggeri ZM. Identification of discontinuous von Willebrand factor sequences involved in complex formation with Botrocetin: a model for the regulation of von Willebrand factor binding to platelet glycoprotein lb. J. Biol. Chem. 1991; 266: 18172-18178
    PubMedGoogle Scholar
  • 41 Ginsburg D, Sadler JE. von Willebrand Disease: A Database of point mutations, insertions and deletions. Thromb Haemost 1993; 69: 177-184
    Article in Thieme ConnectPubMedGoogle Scholar
  • 42 Farrell DH, Thiagarajan P, Chung DW, Davie EW. Role of fibrinogen a and gamma chain sites in platelet aggregation. Proc. Natl. Acad. Sci. USA 1992; 89: 10729-10732
    CrossrefPubMedGoogle Scholar
  • 43 Farrell DH, Thiagarajan P. Binding of recombinant fibrinogen mutants to platelets. J. Biol. Chem. 1994; 269: 226-231
    PubMedGoogle Scholar
  • 44 Savage B, Shattil SJ, Ruggeri ZM. Modulation of platelet function through adhesion receptors: A dual role for glycoprotein Ilb-IIIa (integrin c^Biy mediated by fibrinogen and glycoprotein Ib-von Willebrand factor. J. Biol. Chem. 1992; 267: 11300-11306
    PubMedGoogle Scholar
  • 45 Savage B, Ruggeri ZM. Selective recognition of adhesive sites in surface-bound fibrinogen by GP Ilb-IIIa on nonactivated platelets. J. Biol.Chem. 1991; 266: 11227-11233
    PubMedGoogle Scholar